Share-based Payment Arrangement, Expense of Edwards Lifesciences Corp from 31 Mar 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Edwards Lifesciences Corp quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2010 to 30 Sep 2025.
  • Edwards Lifesciences Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $41,100,000, a 17% increase year-over-year.
  • Edwards Lifesciences Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $152,800,000, a 14% increase year-over-year.
  • Edwards Lifesciences Corp annual Share-based Payment Arrangement, Expense for 2024 was $145,600,000, a 17% increase from 2023.
  • Edwards Lifesciences Corp annual Share-based Payment Arrangement, Expense for 2023 was $124,800,000, a 9.9% increase from 2022.
  • Edwards Lifesciences Corp annual Share-based Payment Arrangement, Expense for 2022 was $113,600,000, a 3.9% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Edwards Lifesciences Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $152,800,000 $41,100,000 +$5,900,000 +17% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $146,900,000 $37,500,000 +$200,000 +0.54% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $146,700,000 $40,100,000 +$1,100,000 +2.8% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $145,600,000 $34,100,000 +$11,000,000 +48% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025 2024 FY
Q3 2024 $134,600,000 $35,200,000 +$6,100,000 +21% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $128,500,000 $37,300,000 +$3,600,000 +11% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $124,900,000 $39,000,000 +$100,000 +0.26% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $124,800,000 $23,100,000 +$8,400,000 +57% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $116,400,000 $29,100,000 -$1,200,000 -4% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $117,600,000 $33,700,000 -$2,500,000 -6.9% 01 Apr 2023 30 Jun 2023 10-Q 31 Jul 2024 2024 Q2
Q1 2023 $120,100,000 $38,900,000 +$6,500,000 +20% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024 2024 Q1
Q4 2022 $113,600,000 $14,700,000 -$9,500,000 -39% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $123,100,000 $30,300,000 +$3,700,000 +14% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023 2023 Q3
Q2 2022 $119,400,000 $36,200,000 +$5,900,000 +19% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023 2023 Q2
Q1 2022 $113,500,000 $32,400,000 +$4,200,000 +15% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q4 2021 $109,300,000 $24,200,000 +$3,300,000 +16% 01 Oct 2021 31 Dec 2021 10-K 12 Feb 2024 2023 FY
Q3 2021 $106,000,000 $26,600,000 +$3,600,000 +16% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 $102,400,000 $30,300,000 +$5,500,000 +22% 01 Apr 2021 30 Jun 2021 10-Q 29 Jul 2022 2022 Q2
Q1 2021 $96,900,000 $28,200,000 +$4,300,000 +18% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q4 2020 $92,600,000 $20,900,000 +$2,500,000 +14% 01 Oct 2020 31 Dec 2020 10-K 13 Feb 2023 2022 FY
Q3 2020 $90,100,000 $23,000,000 +$3,200,000 +16% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021 2021 Q3
Q2 2020 $86,900,000 $24,800,000 +$2,500,000 +11% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $84,400,000 $23,900,000 +$3,100,000 +15% 01 Jan 2020 31 Mar 2020 10-Q 28 Apr 2021 2021 Q1
Q4 2019 $81,300,000 $18,400,000 +$3,200,000 +21% 01 Oct 2019 31 Dec 2019 10-K 14 Feb 2022 2021 FY
Q3 2019 $78,100,000 $19,800,000 +$2,400,000 +14% 01 Jul 2019 30 Sep 2019 10-Q 26 Oct 2020 2020 Q3
Q2 2019 $75,700,000 $22,300,000 +$3,100,000 +16% 01 Apr 2019 30 Jun 2019 10-Q 27 Jul 2020 2020 Q2
Q1 2019 $72,600,000 $20,800,000 +$1,600,000 +8.3% 01 Jan 2019 31 Mar 2019 10-Q 28 Apr 2020 2020 Q1
Q4 2018 $71,000,000 $15,200,000 -$100,000 -0.65% 01 Oct 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
Q3 2018 $71,100,000 $17,400,000 +$1,600,000 +10% 01 Jul 2018 30 Sep 2018 10-Q 25 Oct 2019 2019 Q3
Q2 2018 $69,500,000 $19,200,000 +$3,900,000 +25% 01 Apr 2018 30 Jun 2018 10-Q 27 Jul 2018 2018 Q2
Q1 2018 $65,600,000 $19,200,000 +$4,000,000 +26% 01 Jan 2018 31 Mar 2018 10-Q 26 Jul 2019 2019 Q2
Q4 2017 $61,600,000 $15,300,000 +$1,400,000 +10% 01 Oct 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
Q3 2017 $60,200,000 $15,800,000 +$1,400,000 +9.7% 01 Jul 2017 30 Sep 2017 10-Q 26 Oct 2018 2018 Q3
Q2 2017 $58,800,000 $15,300,000 +$1,000,000 +7% 01 Apr 2017 30 Jun 2017 10-Q 27 Jul 2018 2018 Q2
Q1 2017 $57,800,000 $15,200,000 +$900,000 +6.3% 01 Jan 2017 31 Mar 2017 10-Q 27 Apr 2018 2018 Q1
Q4 2016 $56,900,000 $13,900,000 +$1,000,000 +7.8% 01 Oct 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
Q3 2016 $55,900,000 $14,400,000 +$1,800,000 +14% 01 Jul 2016 30 Sep 2016 10-Q 27 Oct 2017 2017 Q3
Q2 2016 $54,100,000 $14,300,000 +$3,500,000 +32% 01 Apr 2016 30 Jun 2016 10-Q 28 Jul 2017 2017 Q2
Q1 2016 $50,600,000 $14,300,000 +$700,000 +5.1% 01 Jan 2016 31 Mar 2016 10-Q 28 Apr 2017 2017 Q1
Q4 2015 $49,900,000 $12,900,000 +$700,000 +5.7% 01 Oct 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
Q3 2015 $49,200,000 $12,600,000 +$400,000 +3.3% 01 Jul 2015 30 Sep 2015 10-Q 28 Oct 2016 2016 Q3
Q2 2015 $48,800,000 $10,800,000 -$1,100,000 -9.2% 01 Apr 2015 30 Jun 2015 10-Q 29 Jul 2016 2016 Q2
Q1 2015 $49,900,000 $13,600,000 +$1,600,000 +13% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016 2016 Q1
Q4 2014 $48,300,000 $12,200,000 +$700,000 +6.1% 01 Oct 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
Q3 2014 $47,600,000 $12,200,000 +$300,000 +2.5% 01 Jul 2014 30 Sep 2014 10-Q 29 Oct 2015 2015 Q3
Q2 2014 $47,300,000 $11,900,000 -$900,000 -7% 01 Apr 2014 30 Jun 2014 10-Q 29 Jul 2015 2015 Q2
Q1 2014 $48,200,000 $12,000,000 +$800,000 +7.1% 01 Jan 2014 31 Mar 2014 10-Q 29 Apr 2015 2015 Q1
Q4 2013 $47,400,000 $11,500,000 +$700,000 +6.5% 01 Oct 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
Q3 2013 $46,700,000 $11,900,000 +$1,000,000 +9.2% 01 Jul 2013 30 Sep 2013 10-Q 31 Oct 2014 2014 Q3
Q2 2013 $45,700,000 $12,800,000 +$1,600,000 +14% 01 Apr 2013 30 Jun 2013 10-Q 04 Aug 2014 2014 Q2
Q1 2013 $44,100,000 $11,200,000 +$2,000,000 +22% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014 2014 Q1
Q4 2012 $42,100,000 $10,800,000 +$1,800,000 +20% 01 Oct 2012 31 Dec 2012 10-K 20 Feb 2015 2014 FY
Q3 2012 $40,300,000 $10,900,000 +$400,000 +3.8% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q3
Q2 2012 $39,900,000 $11,200,000 +$3,400,000 +44% 01 Apr 2012 30 Jun 2012 10-Q 06 Aug 2013 2013 Q2
Q1 2012 $36,500,000 $9,200,000 +$1,500,000 +19% 01 Jan 2012 31 Mar 2012 10-Q 06 May 2013 2013 Q1
Q4 2011 $35,000,000 $9,000,000 +$2,100,000 +30% 01 Oct 2011 31 Dec 2011 10-K 28 Feb 2014 2013 FY
Q3 2011 $32,900,000 $10,500,000 +$1,900,000 +22% 01 Jul 2011 30 Sep 2011 10-Q 07 Nov 2012 2012 Q3
Q2 2011 $31,000,000 $7,800,000 +$1,500,000 +24% 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012 2012 Q2
Q1 2011 $29,500,000 $7,700,000 +$200,000 +2.7% 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1
Q4 2010 $29,300,000 $6,900,000 01 Oct 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
Q3 2010 $8,600,000 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011 2011 Q3
Q2 2010 $6,300,000 01 Apr 2010 30 Jun 2010 10-Q 08 Aug 2011 2011 Q2
Q1 2010 $7,500,000 01 Jan 2010 31 Mar 2010 10-Q 09 May 2011 2011 Q1

Edwards Lifesciences Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $145,600,000 +$20,800,000 +17% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025 2024 FY
2023 $124,800,000 +$11,200,000 +9.9% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
2022 $113,600,000 +$4,300,000 +3.9% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $109,300,000 +$16,700,000 +18% 01 Jan 2021 31 Dec 2021 10-K 12 Feb 2024 2023 FY
2020 $92,600,000 +$11,300,000 +14% 01 Jan 2020 31 Dec 2020 10-K 13 Feb 2023 2022 FY
2019 $81,300,000 +$10,300,000 +15% 01 Jan 2019 31 Dec 2019 10-K 14 Feb 2022 2021 FY
2018 $71,000,000 +$9,400,000 +15% 01 Jan 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
2017 $61,600,000 +$4,700,000 +8.3% 01 Jan 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
2016 $56,900,000 +$7,000,000 +14% 01 Jan 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
2015 $49,900,000 +$1,600,000 +3.3% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
2014 $48,300,000 +$900,000 +1.9% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $47,400,000 +$5,300,000 +13% 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
2012 $42,100,000 +$7,100,000 +20% 01 Jan 2012 31 Dec 2012 10-K 20 Feb 2015 2014 FY
2011 $35,000,000 +$5,700,000 +19% 01 Jan 2011 31 Dec 2011 10-K 28 Feb 2014 2013 FY
2010 $29,300,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.